Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Biol Chem
2008 Nov 21;28347:32889-99. doi: 10.1074/jbc.M804497200.
Show Gene links
Show Anatomy links
Erythrocytic adenosine monophosphate as an alternative purine source in Plasmodium falciparum.
Cassera MB
,
Hazleton KZ
,
Riegelhaupt PM
,
Merino EF
,
Luo M
,
Akabas MH
,
Schramm VL
.
Abstract
Plasmodium falciparum is a purine auxotroph, salvaging purines from erythrocytes for synthesis of RNA and DNA. Hypoxanthine is the key precursor for purine metabolism in Plasmodium. Inhibition of hypoxanthine-forming reactions in both erythrocytes and parasites is lethal to cultured P. falciparum. We observed that high concentrations of adenosine can rescue cultured parasites from purine nucleoside phosphorylase and adenosine deaminase blockade but not when erythrocyte adenosine kinase is also inhibited. P. falciparum lacks adenosine kinase but can salvage AMP synthesized in the erythrocyte cytoplasm to provide purines when both human and Plasmodium purine nucleoside phosphorylases and adenosine deaminases are inhibited. Transport studies in Xenopus laevis oocytes expressing the P. falciparum nucleoside transporter PfNT1 established that this transporter does not transport AMP. These metabolic patterns establish the existence of a novel nucleoside monophosphate transport pathway in P. falciparum.
Allen,
The membrane potential of the intraerythrocytic malaria parasite Plasmodium falciparum.
2004, Pubmed
Allen,
The membrane potential of the intraerythrocytic malaria parasite Plasmodium falciparum.
2004,
Pubmed
Berman,
Xanthine oxidase inhibits growth of Plasmodium falciparum in human erythrocytes in vitro.
1991,
Pubmed
Beutler,
Metabolic compensation for profound erythrocyte adenylate kinase deficiency. A hereditary enzyme defect without hemolytic anemia.
1983,
Pubmed
Boison,
Adenosine as a neuromodulator in neurological diseases.
2008,
Pubmed
Boison,
The adenosine kinase hypothesis of epileptogenesis.
2008,
Pubmed
Bruns,
Adenosine receptor activation by adenine nucleotides requires conversion of the nucleotides to adenosine.
1980,
Pubmed
Carter,
Isolation and functional characterization of the PfNT1 nucleoside transporter gene from Plasmodium falciparum.
2000,
Pubmed
,
Xenbase
Choi,
Plasmodium falciparum: ATP/ADP transport across the parasitophorous vacuolar and plasma membranes.
1990,
Pubmed
Desjardins,
Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique.
1979,
Pubmed
Downie,
Transport of nucleosides across the Plasmodium falciparum parasite plasma membrane has characteristics of PfENT1.
2006,
Pubmed
,
Xenbase
Downie,
Purine nucleobase transport in the intraerythrocytic malaria parasite.
2008,
Pubmed
,
Xenbase
El Bissati,
The plasma membrane permease PfNT1 is essential for purine salvage in the human malaria parasite Plasmodium falciparum.
2006,
Pubmed
Gardner,
Genome sequence of the human malaria parasite Plasmodium falciparum.
2002,
Pubmed
Hyde,
Drug-resistant malaria.
2005,
Pubmed
Hyde,
Targeting purine and pyrimidine metabolism in human apicomplexan parasites.
2007,
Pubmed
Hyde,
Drug-resistant malaria - an insight.
2007,
Pubmed
Jansen,
State-dependent cross-linking of the M2 and M3 segments: functional basis for the alignment of GABAA and acetylcholine receptor M3 segments.
2006,
Pubmed
,
Xenbase
Jespersen,
Dual-function vector for protein expression in both mammalian cells and Xenopus laevis oocytes.
2002,
Pubmed
,
Xenbase
Kanaani,
Metabolic interconnection between the human malarial parasite Plasmodium falciparum and its host erythrocyte. Regulation of ATP levels by means of an adenylate translocator and adenylate kinase.
1989,
Pubmed
Kicska,
Purine-less death in Plasmodium falciparum induced by immucillin-H, a transition state analogue of purine nucleoside phosphorylase.
2002,
Pubmed
Kimura,
N-linked glycoproteins are related to schizogony of the intraerythrocytic stage in Plasmodium falciparum.
1996,
Pubmed
Komarova,
Adenine nucleotide synthesis in human erythrocytes depends on the mode of supplementation of cell suspension with adenosine.
1999,
Pubmed
Lambros,
Synchronization of Plasmodium falciparum erythrocytic stages in culture.
1979,
Pubmed
Lewandowicz,
Achieving the ultimate physiological goal in transition state analogue inhibitors for purine nucleoside phosphorylase.
2003,
Pubmed
Luo,
Transition-state variation in human, bovine, and Plasmodium falciparum adenosine deaminases.
2007,
Pubmed
Luo,
Transition state structure of E. coli tRNA-specific adenosine deaminase.
2008,
Pubmed
Martin,
The 'permeome' of the malaria parasite: an overview of the membrane transport proteins of Plasmodium falciparum.
2005,
Pubmed
Matsuoka,
Adenine nucleotide-induced activation of adenosine A(2B) receptors expressed in Xenopus laevis oocytes: involvement of a rapid and localized adenosine formation by ectonucleotidases.
2002,
Pubmed
,
Xenbase
McGaraughty,
Anticonvulsant and antinociceptive actions of novel adenosine kinase inhibitors.
2005,
Pubmed
Mohrenweiser,
Characteristics of enzymes of erythrocytes from newborn infants and adults: activity, thermostability, and electrophoretic profile as a function of cell age.
1981,
Pubmed
Parker,
Identification of a nucleoside/nucleobase transporter from Plasmodium falciparum, a novel target for anti-malarial chemotherapy.
2000,
Pubmed
,
Xenbase
Quashie,
An improved and highly sensitive microfluorimetric method for assessing susceptibility of Plasmodium falciparum to antimalarial drugs in vitro.
2006,
Pubmed
Quashie,
A comprehensive model of purine uptake by the malaria parasite Plasmodium falciparum: identification of four purine transport activities in intraerythrocytic parasites.
2008,
Pubmed
Rager,
Localization of the Plasmodium falciparum PfNT1 nucleoside transporter to the parasite plasma membrane.
2001,
Pubmed
Razakantoanina,
Plasmodium falciparum: functional mitochondrial ADP/ATP transporter in Escherichia coli plasmic membrane as a tool for selective drug screening.
2008,
Pubmed
Reyes,
Enzymes of purine and pyrimidine metabolism from the human malaria parasite, Plasmodium falciparum.
1982,
Pubmed
Saliba,
Sodium-dependent uptake of inorganic phosphate by the intracellular malaria parasite.
2006,
Pubmed
,
Xenbase
Sanchez,
Nucleotide transport in African trypanosomes.
1976,
Pubmed
Shi,
Plasmodium falciparum purine nucleoside phosphorylase: crystal structures, immucillin inhibitors, and dual catalytic function.
2004,
Pubmed
Simmonds,
ATP formation from deoxyadenosine in human erythrocytes: evidence for a hitherto unidentified route involving adenine and S-adenosylhomocysteine hydrolase.
1989,
Pubmed
Snow,
The global distribution of clinical episodes of Plasmodium falciparum malaria.
2005,
Pubmed
Stein,
Equilibrative nucleoside transporter family members from Leishmania donovani are electrogenic proton symporters.
2003,
Pubmed
,
Xenbase
Ting,
Targeting a novel Plasmodium falciparum purine recycling pathway with specific immucillins.
2005,
Pubmed
Trager,
Human malaria parasites in continuous culture.
1976,
Pubmed
Traut,
Physiological concentrations of purines and pyrimidines.
1994,
Pubmed
Tyler,
Synthesis of 5'-methylthio coformycins: specific inhibitors for malarial adenosine deaminase.
2007,
Pubmed
Webster,
Adenosine deaminase in malaria infection: effect of 2'-deoxycoformycin in vivo.
1984,
Pubmed
Ziganshin,
Characteristics of ecto-ATPase of Xenopus oocytes and the inhibitory actions of suramin on ATP breakdown.
1995,
Pubmed
,
Xenbase
de Koning,
Purine and pyrimidine transport in pathogenic protozoa: from biology to therapy.
2005,
Pubmed
